Back to
BANK OF MONTREAL /CAN/
AMLX
Showing 7 of 10 quarters
Position history for
BANK OF MONTREAL /CAN/'s holdings in AMYLYX PHARMACEUTICALS INC
No. Bank of Montreal exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 138,525 shares worth $1.7M. Bank of Montreal first reported AMLX in Q2 2023 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$442,017
Total Shares Change
-143,512
Quarter-by-Quarter History